CLINICAL_TRIALS ClinicalTrials.gov record update

A 12-week Open-label, Randomised, Parallel-group, Multicentre, Phase IIIb Study to Compare the Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe and Simvastatin in Patients With Hypercholesterolaemia and CHD

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00525824
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:10.894725+00:00
Published At: 2009-10-07T00:00:00+00:00
Record Updated At: 2011-05-13
Results Posted At: 2009-10-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hypercholesterolemia", "Coronary Heart Disease", "Atherosclerosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2011-05-13"
protocolSection.identificationModule.nctId: "NCT00525824"
protocolSection.identificationModule.officialTitle: "A 12-week Open-label, Randomised, Parallel-group, Multicentre, Phase IIIb Study to Compare the Efficacy and Safety of Rosuvastatin (CRESTOR\u2122) in Combination With Ezetimibe and Simvastatin in Patients With Hypercholesterolaemia and CHD"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2009-10-07"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.